Incorporation of Drug Efflux Inhibitor and Chemotherapeutic Agent Into an Inorganic/Organic Platform for the Effective Treatment of Multidrug Resistant Breast Cancer

Journal of Nanobiotechnology- United Kingdom

doi 10.1186/s12951-019-0559-y

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Activity of the Efflux Pump Inhibitor SILA 421 Against Drug-Resistant Tuberculosis

International Journal of Antimicrobial Agents
MedicineInfectious DiseasesMicrobiologyPharmacology
2013English

pH and Near-Infrared Light Dual-Stimuli Responsive Drug Delivery Using DNA-conjugated Gold Nanorods for Effective Treatment of Multidrug Resistant Cancer Cells

Journal of Controlled Release
Pharmaceutical Science
2016English

Trafficking Microenvironmental pHs of Polycationic Gene Vectors in Drug-Sensitive and Multidrug-Resistant McF7 Breast Cancer Cells

Biomaterials
Mechanics of MaterialsBiophysicsBiomaterialsBioengineeringCompositesNanoscienceNanotechnologyCeramics
2010English

Punica Granatum Rind Extract: Antibiotic Potentiator and Efflux Pump Inhibitor of Multidrug Resistant Klebsiella Pneumoniae Clinical Isolates

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2017English

Identification of a Novel Topoisomerase Inhibitor Effective in Cells Overexpressing Drug Efflux Transporters

PLoS ONE
Multidisciplinary
2009English

Clofazimine for the Treatment of Multidrug-Resistant Tuberculosis

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2019English

Therapeutic Drug Management: Is It the Future of Multidrug-Resistant Tuberculosis Treatment?

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2013English

Enhancing the Efficacy of Chemotherapeutic Breast Cancer Treatment With Nonanticoagulant Heparins

2010English

Nanomicellar Paclitaxel Increases Cytotoxicity of Multidrug Resistant Breast Cancer Cells

Cancer Letters
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy